Increasing Access to Smoking Cessation and Smoke Free Home Services for Low-Income Pregnant Women in Northeast Texas

NCT05051345 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 191

Last updated 2026-05-15

No results posted yet for this study

Summary

This trial seeks to increase access to smoking cessation services to low-income pregnant women. Smoking is associated with an increased risk of developing cancer. Smoking during pregnancy smoking is associated with an increased risk of low birth weight, a condition that is associated with neonatal, perinatal, and infant morbidity and mortality. The overall goal of this trial is to help patients make healthy choices and provide support during pregnancy and in the first few months after the birth of the baby.

Conditions

  • Cigarette Smoking-Related Carcinoma

Interventions

BEHAVIORAL

Smoking Cessation Intervention

Receive Smoke-Free Homes kit

OTHER

Survey Administration

Ancillary studies

BEHAVIORAL

Telephone-Based Intervention

Receive telephone counseling sessions

BEHAVIORAL

Telephone-Based Intervention

Receive a coaching call from a Baby Steps for Health counselor

OTHER

Tobacco Cessation Counseling

Receive telephone counseling sessions

OTHER

Informational Intervention

Receive information on the services provided for pregnant women and smoking cessation

OTHER

Informational Intervention

Receive tobacco cessation self-help materials

OTHER

Informational Intervention

Receive Smoke-Free Homes mailings

OTHER

Media Intervention

Download and use the Wellness app

OTHER

Questionnaire Administration

Ancillary studies

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH
  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Jan Blalock · M.D. Anderson Cancer Center

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-02-18
Primary Completion
2026-05-08
Completion
2026-05-08

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05051345 on ClinicalTrials.gov